Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical and early clinical findings for TAK-013, a potent oral GnRH receptor antagonist

June 27, 2002

Angiogenesis inhibitors in early development at Sigma-Tau

June 27, 2002

Nonapprovable letter issued for Casodex in early prostate cancer

June 27, 2002

Antiestrogenic effects of Sch-57068 in female reproductive organs examined in detail in rats

June 26, 2002

Introgen's Advexin receives proprietary name approval from FDA

June 26, 2002

Potent HDAC inhibitors identified at Abbott with submicromolar antitumor activity

June 26, 2002

Oral retinoid for CTCL introduced in Germany

June 26, 2002

BioVex commences phase I trial of OncoVEX GM-CSF for solid tumors

June 26, 2002

Novel antitumor naphthyridines identified by Dainippon

June 25, 2002

BioCryst describes PNP inhibitors with potential in cancer therapy

June 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...